EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Glucagon‐Like Peptide‐1 Targets in the Human Nodose Ganglion

Warda Merchant, Claire Mackaaij, Cindy G J Cleypool, Laurent Gautron iD

Journal of Comparative Neurology · 2026

DOI: 10.1002/cne.70135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Comparative Neurology, 2026. Verfasst von Warda Merchant und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Center for Hypothalamic Research, UT Southwestern Medical Center, Dallas, Texas, USA. Hauptthemen laut MEDLINE: Nodose Ganglion, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide 1. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Given the rapidly expanding clinical use of glucagon‐like peptide‐1 receptor (GLP1R) agonists—well‐known for their antidiabetic and antiobesity effects—it is increasingly important to understand the precise distribution of GLP1R expression in the human body, as this knowledge is crucial for elucidating both their therapeutic effects and side effects. In this study, we investigated Glp1r mRNA expression in the human nodose ganglion, a key sensory relay between the periphery and the brain. We analyzed postmortem paraffin‐embedded nodose ganglia sections from 10 human donors, using RNAscope analysis. We found that optimal tissue required fixation times under 48 h and postmortem intervals of approximately 10 h or less. Ultimately, nine nodose ganglia from six donors met quality standards for analysis. Using multiplex RNAscope, we detected moderate to high levels of Glp1r expression in approximately 7% of all nodose neurons, with no clear differences between sides, sex, or age. The proportion of neurons with low Glp1r expression rose to nearly 28%. Notably, Glp1r expression was also observed in nonneuronal cells within the perineurium, epineurium, and fascicles of the human vagus nerve. As a point of comparison, we also examined Glp1r expression in mice, where 17.9%–29.1% of nodose neurons were positive, with slightly higher expression on the right side. In mice, Glp1r expression was strictly neuronal. Overall, our findings demonstrate that the human nodose ganglion is a potential target for GLP1R‐based therapeutics and reveal species similarities and differences in Glp1r expression between humans and mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nodose GanglionGlucagon-Like Peptide-1 ReceptorGlucagon-Like Peptide 1HumansFemaleMaleAnimalsMiddle AgedAdultAgedMiceRNA, MessengerAged, 80 and overNeuronsMice, Inbred C57BL

Stichwörter der Autor:innen

Glp1rHomo sapiensautonomic nervous systemendocrinologyhumanin situ hybridizationnodose ganglionperipheral afferent neurons

Substanzen

Glucagon-Like Peptide-1 ReceptorGLP1R protein, humanGlucagon-Like Peptide 1RNA, MessengerGlp1r protein, mouse

Autor:innen und Institutionen

  • Department of Internal Medicine and Center for Hypothalamic Research, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Division of Surgical Specialties, Department of Anatomy, University Medical Center, Utrecht, The Netherlands.

ORCID-Profile: Laurent Gautron

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Merchant, W., Mackaaij, C., Cleypool, C. G. J., & Gautron, L. (2026). Glucagon‐Like Peptide‐1 Targets in the Human Nodose Ganglion. Journal of Comparative Neurology. https://doi.org/10.1002/cne.70135

Vancouver

Merchant W, Mackaaij C, Cleypool CGJ, Gautron L. Glucagon‐Like Peptide‐1 Targets in the Human Nodose Ganglion. Journal of Comparative Neurology. 2026. doi:10.1002/cne.70135

BibTeX
@article{Merchant2026,
  author = {Merchant, Warda and Mackaaij, Claire and Cleypool, Cindy G J and Gautron, Laurent},
  title = {Glucagon‐Like Peptide‐1 Targets in the Human Nodose Ganglion},
  journal = {Journal of Comparative Neurology},
  year = {2026},
  doi = {10.1002/cne.70135}
}
Kostenlos starten →